A small team in Brisbane are on the global antibiotic discovery map with their collaborative approach to fixing the antibiotic pipeline. They have become a benchmark network for researchers to join the antimicrobial resistance (AMR) field and advancing the AMR agenda in governments worldwide.

As antibiotics have become more common, so too have bacteria that are immune to their effects. Bill Condie explains why, and talks to CO-ADD scientists building the weapons for the next phase of this arms race.